For interview requests or other media engagements, email our communications team at info@airna.com.

Press Releases

1 October 2025

AIRNA Appoints Allison Dorval as Chief Financial Officer and Niru Subramanian as Chief Operating Officer

Cambridge, MA, USA and Tübingen, Germany, October 1, 2025 – AIRNA, a biotech company pioneering RNA editing therapeutics to transform the lives of patients with rare and common conditions, today announced the appointments of Allison Dorval as Chief Financial Officer (CFO) and Niru Subramanian as Chief Operating Officer (COO). “AIRNA is at an exciting inflection point as […]

Read

6 August 2025

AIRNA Appoints Tamara Joseph as Chief Legal Officer and Kristina Storey as Head of Regulatory Affairs

Cambridge, MA, USA and Tübingen, Germany, August 6, 2025 – AIRNA, a biotech company pioneering RNA editing therapeutics to transform the lives of patients with rare and common conditions, today announced the appointments of Tamara Joseph, J.D., L.L.M., as Chief Legal Officer (CLO) and Kristina Storey as Senior Vice President (SVP), Head of Regulatory Affairs. “These appointments […]

Read

In the News

In the News

GEN Edge

|

31 July 2024

RNA Editing Therapy Developer Closes $60M Series A Financing

View

In the News

BioPharma Dive

|

31 July 2024

Biotech Airna raises $60M for RNA editing medicines

View